Status:
COMPLETED
Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Healthy
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Evaluate if gene expression changes in SOD2 explain the health benefits of high polyphenols cocoa
Detailed Description
Evaluate if gene expression changes in SOD2 explain the health benefits of high polyphenols cocoa.
Eligibility Criteria
Inclusion
- Healthy adults
- BMI between 18.5 and 30 kg/m2
- Sedentary to moderate physical activity habits
Exclusion
- Consumption of dietary supplements, antioxidants or anti-inflammatory medication, such as aspirin, ibuprofen, naproxen, or any medication that can affect the study outcomes
- Actively smoking
- Suspected abuse of alcohol or illicit drugs
- Significant illness within two weeks prior to study start or any active systemic infection or medical condition that may require treatment or therapeutic intervention during the study
- Subject who cannot be expected to comply with study procedures
- Currently participating or having participated in another clinical trial during last 4 weeks prior to the beginning of this study
- Consumption of chocolate or its derivates 24 hours before the blood sample taken
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02292576
Start Date
June 1 2012
End Date
August 1 2014
Last Update
November 17 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.